Business Leaders

Margareta Elisabeth Björk

Alter : 61

Größte Unternehmen :

AstraZeneca PLC -

Rocket Pharmaceuticals, Inc. -

Calliditas Therapeutics AB (publ) -

Pharvaris N.V.

Übersicht

Margareta Elisabeth Björk is Senior VP & Head-Late-stage Development at AstraZeneca Plc and Associate Professor at the University of Uppsala and on the board of 6 other companies.

She previously was Head-Diabetes & Endocrinology Unit at Uppsala University Hospital.

She received a doctorate from Karolinska Institutet.

Aktuelle Stellungen und Verantwortungsbereiche Margareta Elisabeth Björk

Name	Titel	Seit
Rocket Pharmaceuticals, Inc. (Biotechnologie)	Independent Director	2020
Calliditas Therapeutics AB (publ) (Pharmazeutika)	Non-Executive Director	2022
Pharvaris N.V. (Biotechnologie)	Independent Non-Executive Director	2021
AstraZeneca PLC (Pharmazeutika)	Senior VP & Head-Late-stage Development	-
Chalmers University of Technology	Director	-
Björks Matematik o Mera AB	Director	-
Rfidcompare Europe AB	Director	-
University of Uppsala	Associate Professor	-

Anteile an Margareta Elisabeth Björk

Name	Aktien	%	Bewertung
Rocket Pharmaceuticals, Inc. (RCKT) (Biotechnologie)	0	0,0000%	0 USD

Margareta Elisabeth Björk: Persönliches Netzwerk

Name	Verbundene Unternehmen
Anne Lesage	Pharvaris N.V.
David P. Southwell	Rocket Pharmaceuticals, Inc.
Anne Marie de Jonge Schuermans	Pharvaris N.V.
Raj Prabhakar	Rocket Pharmaceuticals, Inc.
Mayur Kasetty	Rocket Pharmaceuticals, Inc.
Peng Lu	Pharvaris N.V.
Gotham Makker	Rocket Pharmaceuticals, Inc.
Mayo Pujols	Rocket Pharmaceuticals, Inc.
Gaurav D. Shah	Rocket Pharmaceuticals, Inc.
Martin L. Wilson	Rocket Pharmaceuticals, Inc.